nodes	percent_of_prediction	percent_of_DWPC	metapath
Ertapenem—Herpes simplex—Methotrexate—esophageal cancer	0.00282	0.00282	CcSEcCtD
Ertapenem—Renal failure acute—Capecitabine—esophageal cancer	0.00274	0.00274	CcSEcCtD
Ertapenem—Hot flush—Capecitabine—esophageal cancer	0.00271	0.00271	CcSEcCtD
Ertapenem—Menopausal symptoms—Capecitabine—esophageal cancer	0.00269	0.00269	CcSEcCtD
Ertapenem—Atrial fibrillation—Capecitabine—esophageal cancer	0.00267	0.00267	CcSEcCtD
Ertapenem—Thirst—Capecitabine—esophageal cancer	0.00266	0.00266	CcSEcCtD
Ertapenem—Vasculitis—Methotrexate—esophageal cancer	0.00266	0.00266	CcSEcCtD
Ertapenem—Vaginal inflammation—Methotrexate—esophageal cancer	0.0026	0.0026	CcSEcCtD
Ertapenem—Pulmonary embolism—Methotrexate—esophageal cancer	0.0026	0.0026	CcSEcCtD
Ertapenem—Cardiac failure—Capecitabine—esophageal cancer	0.0026	0.0026	CcSEcCtD
Ertapenem—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00259	0.00259	CcSEcCtD
Ertapenem—Stomatitis—Cisplatin—esophageal cancer	0.00258	0.00258	CcSEcCtD
Ertapenem—Melaena—Methotrexate—esophageal cancer	0.00254	0.00254	CcSEcCtD
Ertapenem—Pain in extremity—Capecitabine—esophageal cancer	0.00253	0.00253	CcSEcCtD
Ertapenem—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00253	0.00253	CcSEcCtD
Ertapenem—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00251	0.00251	CcSEcCtD
Ertapenem—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00251	0.00251	CcSEcCtD
Ertapenem—Skin exfoliation—Methotrexate—esophageal cancer	0.00248	0.00248	CcSEcCtD
Ertapenem—Vaginal infection—Methotrexate—esophageal cancer	0.00245	0.00245	CcSEcCtD
Ertapenem—Face oedema—Capecitabine—esophageal cancer	0.00245	0.00245	CcSEcCtD
Ertapenem—Bradycardia—Cisplatin—esophageal cancer	0.00242	0.00242	CcSEcCtD
Ertapenem—Cardiac arrest—Capecitabine—esophageal cancer	0.00241	0.00241	CcSEcCtD
Ertapenem—Urinary retention—Capecitabine—esophageal cancer	0.00241	0.00241	CcSEcCtD
Ertapenem—Blood creatinine increased—Capecitabine—esophageal cancer	0.00237	0.00237	CcSEcCtD
Ertapenem—Dehydration—Capecitabine—esophageal cancer	0.00236	0.00236	CcSEcCtD
Ertapenem—Mouth ulceration—Methotrexate—esophageal cancer	0.00235	0.00235	CcSEcCtD
Ertapenem—Urinary tract disorder—Cisplatin—esophageal cancer	0.00235	0.00235	CcSEcCtD
Ertapenem—Connective tissue disorder—Cisplatin—esophageal cancer	0.00234	0.00234	CcSEcCtD
Ertapenem—Urethral disorder—Cisplatin—esophageal cancer	0.00233	0.00233	CcSEcCtD
Ertapenem—Abdominal pain upper—Capecitabine—esophageal cancer	0.00231	0.00231	CcSEcCtD
Ertapenem—Breast disorder—Capecitabine—esophageal cancer	0.00229	0.00229	CcSEcCtD
Ertapenem—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00228	0.00228	CcSEcCtD
Ertapenem—Nasopharyngitis—Capecitabine—esophageal cancer	0.00227	0.00227	CcSEcCtD
Ertapenem—Sepsis—Methotrexate—esophageal cancer	0.00226	0.00226	CcSEcCtD
Ertapenem—Gastritis—Capecitabine—esophageal cancer	0.00224	0.00224	CcSEcCtD
Ertapenem—Muscular weakness—Capecitabine—esophageal cancer	0.00223	0.00223	CcSEcCtD
Ertapenem—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00223	0.00223	CcSEcCtD
Ertapenem—Eye disorder—Cisplatin—esophageal cancer	0.00222	0.00222	CcSEcCtD
Ertapenem—Cardiac disorder—Cisplatin—esophageal cancer	0.00221	0.00221	CcSEcCtD
Ertapenem—Flushing—Cisplatin—esophageal cancer	0.00221	0.00221	CcSEcCtD
Ertapenem—Abdominal distension—Capecitabine—esophageal cancer	0.0022	0.0022	CcSEcCtD
Ertapenem—Asthma—Capecitabine—esophageal cancer	0.00219	0.00219	CcSEcCtD
Ertapenem—Dysphagia—Capecitabine—esophageal cancer	0.00219	0.00219	CcSEcCtD
Ertapenem—Thrombophlebitis—Methotrexate—esophageal cancer	0.00218	0.00218	CcSEcCtD
Ertapenem—Diabetes mellitus—Methotrexate—esophageal cancer	0.00217	0.00217	CcSEcCtD
Ertapenem—Bronchospasm—Capecitabine—esophageal cancer	0.00215	0.00215	CcSEcCtD
Ertapenem—Immune system disorder—Cisplatin—esophageal cancer	0.00215	0.00215	CcSEcCtD
Ertapenem—Mediastinal disorder—Cisplatin—esophageal cancer	0.00214	0.00214	CcSEcCtD
Ertapenem—Arrhythmia—Cisplatin—esophageal cancer	0.00212	0.00212	CcSEcCtD
Ertapenem—Erythema—Cisplatin—esophageal cancer	0.00207	0.00207	CcSEcCtD
Ertapenem—Malnutrition—Cisplatin—esophageal cancer	0.00207	0.00207	CcSEcCtD
Ertapenem—Dysuria—Capecitabine—esophageal cancer	0.00205	0.00205	CcSEcCtD
Ertapenem—Neutropenia—Capecitabine—esophageal cancer	0.00205	0.00205	CcSEcCtD
Ertapenem—Renal failure acute—Methotrexate—esophageal cancer	0.00204	0.00204	CcSEcCtD
Ertapenem—Flatulence—Cisplatin—esophageal cancer	0.00204	0.00204	CcSEcCtD
Ertapenem—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00204	0.00204	CcSEcCtD
Ertapenem—Muscle spasms—Cisplatin—esophageal cancer	0.00199	0.00199	CcSEcCtD
Ertapenem—Weight decreased—Capecitabine—esophageal cancer	0.00198	0.00198	CcSEcCtD
Ertapenem—Pneumonia—Capecitabine—esophageal cancer	0.00196	0.00196	CcSEcCtD
Ertapenem—Infestation—Capecitabine—esophageal cancer	0.00195	0.00195	CcSEcCtD
Ertapenem—Infestation NOS—Capecitabine—esophageal cancer	0.00195	0.00195	CcSEcCtD
Ertapenem—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00195	0.00195	CcSEcCtD
Ertapenem—Tremor—Cisplatin—esophageal cancer	0.00194	0.00194	CcSEcCtD
Ertapenem—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00193	0.00193	CcSEcCtD
Ertapenem—Ill-defined disorder—Cisplatin—esophageal cancer	0.00192	0.00192	CcSEcCtD
Ertapenem—Anaemia—Cisplatin—esophageal cancer	0.00191	0.00191	CcSEcCtD
Ertapenem—Jaundice—Capecitabine—esophageal cancer	0.0019	0.0019	CcSEcCtD
Ertapenem—Stomatitis—Capecitabine—esophageal cancer	0.0019	0.0019	CcSEcCtD
Ertapenem—Urinary tract infection—Capecitabine—esophageal cancer	0.0019	0.0019	CcSEcCtD
Ertapenem—Malaise—Cisplatin—esophageal cancer	0.00187	0.00187	CcSEcCtD
Ertapenem—Haematuria—Capecitabine—esophageal cancer	0.00186	0.00186	CcSEcCtD
Ertapenem—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00185	0.00185	CcSEcCtD
Ertapenem—Epistaxis—Capecitabine—esophageal cancer	0.00184	0.00184	CcSEcCtD
Ertapenem—Convulsion—Cisplatin—esophageal cancer	0.00179	0.00179	CcSEcCtD
Ertapenem—Bradycardia—Capecitabine—esophageal cancer	0.00178	0.00178	CcSEcCtD
Ertapenem—Haemoglobin—Capecitabine—esophageal cancer	0.00176	0.00176	CcSEcCtD
Ertapenem—Rhinitis—Capecitabine—esophageal cancer	0.00176	0.00176	CcSEcCtD
Ertapenem—Anxiety—Cisplatin—esophageal cancer	0.00176	0.00176	CcSEcCtD
Ertapenem—Haemorrhage—Capecitabine—esophageal cancer	0.00175	0.00175	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00175	0.00175	CcSEcCtD
Ertapenem—Hypoaesthesia—Capecitabine—esophageal cancer	0.00174	0.00174	CcSEcCtD
Ertapenem—Discomfort—Cisplatin—esophageal cancer	0.00174	0.00174	CcSEcCtD
Ertapenem—Pharyngitis—Capecitabine—esophageal cancer	0.00174	0.00174	CcSEcCtD
Ertapenem—Urinary tract disorder—Capecitabine—esophageal cancer	0.00173	0.00173	CcSEcCtD
Ertapenem—Connective tissue disorder—Capecitabine—esophageal cancer	0.00172	0.00172	CcSEcCtD
Ertapenem—Urethral disorder—Capecitabine—esophageal cancer	0.00172	0.00172	CcSEcCtD
Ertapenem—Breast disorder—Methotrexate—esophageal cancer	0.0017	0.0017	CcSEcCtD
Ertapenem—Anaphylactic shock—Cisplatin—esophageal cancer	0.00169	0.00169	CcSEcCtD
Ertapenem—Oedema—Cisplatin—esophageal cancer	0.00169	0.00169	CcSEcCtD
Ertapenem—Infection—Cisplatin—esophageal cancer	0.00168	0.00168	CcSEcCtD
Ertapenem—Nervous system disorder—Cisplatin—esophageal cancer	0.00166	0.00166	CcSEcCtD
Ertapenem—Thrombocytopenia—Cisplatin—esophageal cancer	0.00165	0.00165	CcSEcCtD
Ertapenem—Tachycardia—Cisplatin—esophageal cancer	0.00165	0.00165	CcSEcCtD
Ertapenem—Skin disorder—Cisplatin—esophageal cancer	0.00164	0.00164	CcSEcCtD
Ertapenem—Eye disorder—Capecitabine—esophageal cancer	0.00164	0.00164	CcSEcCtD
Ertapenem—Hyperhidrosis—Cisplatin—esophageal cancer	0.00163	0.00163	CcSEcCtD
Ertapenem—Asthma—Methotrexate—esophageal cancer	0.00163	0.00163	CcSEcCtD
Ertapenem—Flushing—Capecitabine—esophageal cancer	0.00163	0.00163	CcSEcCtD
Ertapenem—Cardiac disorder—Capecitabine—esophageal cancer	0.00163	0.00163	CcSEcCtD
Ertapenem—Eosinophilia—Methotrexate—esophageal cancer	0.00161	0.00161	CcSEcCtD
Ertapenem—Anorexia—Cisplatin—esophageal cancer	0.00161	0.00161	CcSEcCtD
Ertapenem—Pancreatitis—Methotrexate—esophageal cancer	0.0016	0.0016	CcSEcCtD
Ertapenem—Angiopathy—Capecitabine—esophageal cancer	0.00159	0.00159	CcSEcCtD
Ertapenem—Immune system disorder—Capecitabine—esophageal cancer	0.00158	0.00158	CcSEcCtD
Ertapenem—Mediastinal disorder—Capecitabine—esophageal cancer	0.00158	0.00158	CcSEcCtD
Ertapenem—Hypotension—Cisplatin—esophageal cancer	0.00158	0.00158	CcSEcCtD
Ertapenem—Chills—Capecitabine—esophageal cancer	0.00157	0.00157	CcSEcCtD
Ertapenem—Arrhythmia—Capecitabine—esophageal cancer	0.00157	0.00157	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00154	0.00154	CcSEcCtD
Ertapenem—Mental disorder—Capecitabine—esophageal cancer	0.00154	0.00154	CcSEcCtD
Ertapenem—Malnutrition—Capecitabine—esophageal cancer	0.00153	0.00153	CcSEcCtD
Ertapenem—Erythema—Capecitabine—esophageal cancer	0.00153	0.00153	CcSEcCtD
Ertapenem—Dysuria—Methotrexate—esophageal cancer	0.00152	0.00152	CcSEcCtD
Ertapenem—Neutropenia—Methotrexate—esophageal cancer	0.00152	0.00152	CcSEcCtD
Ertapenem—Paraesthesia—Cisplatin—esophageal cancer	0.00152	0.00152	CcSEcCtD
Ertapenem—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00152	0.00152	CcSEcCtD
Ertapenem—Dyspnoea—Cisplatin—esophageal cancer	0.00151	0.00151	CcSEcCtD
Ertapenem—Flatulence—Capecitabine—esophageal cancer	0.0015	0.0015	CcSEcCtD
Ertapenem—Dysgeusia—Capecitabine—esophageal cancer	0.00149	0.00149	CcSEcCtD
Ertapenem—Decreased appetite—Cisplatin—esophageal cancer	0.00147	0.00147	CcSEcCtD
Ertapenem—Muscle spasms—Capecitabine—esophageal cancer	0.00147	0.00147	CcSEcCtD
Ertapenem—Pneumonia—Methotrexate—esophageal cancer	0.00146	0.00146	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00146	0.00146	CcSEcCtD
Ertapenem—Infestation NOS—Methotrexate—esophageal cancer	0.00145	0.00145	CcSEcCtD
Ertapenem—Infestation—Methotrexate—esophageal cancer	0.00145	0.00145	CcSEcCtD
Ertapenem—Pain—Cisplatin—esophageal cancer	0.00144	0.00144	CcSEcCtD
Ertapenem—Tremor—Capecitabine—esophageal cancer	0.00143	0.00143	CcSEcCtD
Ertapenem—Stomatitis—Methotrexate—esophageal cancer	0.00142	0.00142	CcSEcCtD
Ertapenem—Ill-defined disorder—Capecitabine—esophageal cancer	0.00142	0.00142	CcSEcCtD
Ertapenem—Anaemia—Capecitabine—esophageal cancer	0.00141	0.00141	CcSEcCtD
Ertapenem—Sweating—Methotrexate—esophageal cancer	0.00139	0.00139	CcSEcCtD
Ertapenem—Feeling abnormal—Cisplatin—esophageal cancer	0.00139	0.00139	CcSEcCtD
Ertapenem—Haematuria—Methotrexate—esophageal cancer	0.00139	0.00139	CcSEcCtD
Ertapenem—Malaise—Capecitabine—esophageal cancer	0.00138	0.00138	CcSEcCtD
Ertapenem—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00137	0.00137	CcSEcCtD
Ertapenem—Epistaxis—Methotrexate—esophageal cancer	0.00137	0.00137	CcSEcCtD
Ertapenem—Vertigo—Capecitabine—esophageal cancer	0.00137	0.00137	CcSEcCtD
Ertapenem—Syncope—Capecitabine—esophageal cancer	0.00137	0.00137	CcSEcCtD
Ertapenem—Loss of consciousness—Capecitabine—esophageal cancer	0.00134	0.00134	CcSEcCtD
Ertapenem—Body temperature increased—Cisplatin—esophageal cancer	0.00134	0.00134	CcSEcCtD
Ertapenem—Cough—Capecitabine—esophageal cancer	0.00133	0.00133	CcSEcCtD
Ertapenem—Hypertension—Capecitabine—esophageal cancer	0.00132	0.00132	CcSEcCtD
Ertapenem—Haemoglobin—Methotrexate—esophageal cancer	0.00131	0.00131	CcSEcCtD
Ertapenem—Haemorrhage—Methotrexate—esophageal cancer	0.00131	0.00131	CcSEcCtD
Ertapenem—Arthralgia—Capecitabine—esophageal cancer	0.0013	0.0013	CcSEcCtD
Ertapenem—Chest pain—Capecitabine—esophageal cancer	0.0013	0.0013	CcSEcCtD
Ertapenem—Pharyngitis—Methotrexate—esophageal cancer	0.0013	0.0013	CcSEcCtD
Ertapenem—Anxiety—Capecitabine—esophageal cancer	0.00129	0.00129	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00129	0.00129	CcSEcCtD
Ertapenem—Urinary tract disorder—Methotrexate—esophageal cancer	0.00129	0.00129	CcSEcCtD
Ertapenem—Discomfort—Capecitabine—esophageal cancer	0.00128	0.00128	CcSEcCtD
Ertapenem—Urethral disorder—Methotrexate—esophageal cancer	0.00128	0.00128	CcSEcCtD
Ertapenem—Dry mouth—Capecitabine—esophageal cancer	0.00127	0.00127	CcSEcCtD
Ertapenem—Confusional state—Capecitabine—esophageal cancer	0.00126	0.00126	CcSEcCtD
Ertapenem—Oedema—Capecitabine—esophageal cancer	0.00125	0.00125	CcSEcCtD
Ertapenem—Hypersensitivity—Cisplatin—esophageal cancer	0.00124	0.00124	CcSEcCtD
Ertapenem—Infection—Capecitabine—esophageal cancer	0.00124	0.00124	CcSEcCtD
Ertapenem—Shock—Capecitabine—esophageal cancer	0.00123	0.00123	CcSEcCtD
Ertapenem—Nervous system disorder—Capecitabine—esophageal cancer	0.00122	0.00122	CcSEcCtD
Ertapenem—Eye disorder—Methotrexate—esophageal cancer	0.00122	0.00122	CcSEcCtD
Ertapenem—Thrombocytopenia—Capecitabine—esophageal cancer	0.00122	0.00122	CcSEcCtD
Ertapenem—Tachycardia—Capecitabine—esophageal cancer	0.00122	0.00122	CcSEcCtD
Ertapenem—Asthenia—Cisplatin—esophageal cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Cardiac disorder—Methotrexate—esophageal cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Skin disorder—Capecitabine—esophageal cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Hyperhidrosis—Capecitabine—esophageal cancer	0.0012	0.0012	CcSEcCtD
Ertapenem—Anorexia—Capecitabine—esophageal cancer	0.00119	0.00119	CcSEcCtD
Ertapenem—Angiopathy—Methotrexate—esophageal cancer	0.00118	0.00118	CcSEcCtD
Ertapenem—Immune system disorder—Methotrexate—esophageal cancer	0.00118	0.00118	CcSEcCtD
Ertapenem—Mediastinal disorder—Methotrexate—esophageal cancer	0.00118	0.00118	CcSEcCtD
Ertapenem—Chills—Methotrexate—esophageal cancer	0.00117	0.00117	CcSEcCtD
Ertapenem—Hypotension—Capecitabine—esophageal cancer	0.00116	0.00116	CcSEcCtD
Ertapenem—Diarrhoea—Cisplatin—esophageal cancer	0.00116	0.00116	CcSEcCtD
Ertapenem—Mental disorder—Methotrexate—esophageal cancer	0.00114	0.00114	CcSEcCtD
Ertapenem—Erythema—Methotrexate—esophageal cancer	0.00114	0.00114	CcSEcCtD
Ertapenem—Malnutrition—Methotrexate—esophageal cancer	0.00114	0.00114	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00113	0.00113	CcSEcCtD
Ertapenem—Insomnia—Capecitabine—esophageal cancer	0.00113	0.00113	CcSEcCtD
Ertapenem—Paraesthesia—Capecitabine—esophageal cancer	0.00112	0.00112	CcSEcCtD
Ertapenem—Dysgeusia—Methotrexate—esophageal cancer	0.00111	0.00111	CcSEcCtD
Ertapenem—Dyspnoea—Capecitabine—esophageal cancer	0.00111	0.00111	CcSEcCtD
Ertapenem—Dyspepsia—Capecitabine—esophageal cancer	0.0011	0.0011	CcSEcCtD
Ertapenem—Decreased appetite—Capecitabine—esophageal cancer	0.00108	0.00108	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00108	0.00108	CcSEcCtD
Ertapenem—Vomiting—Cisplatin—esophageal cancer	0.00107	0.00107	CcSEcCtD
Ertapenem—Fatigue—Capecitabine—esophageal cancer	0.00107	0.00107	CcSEcCtD
Ertapenem—Rash—Cisplatin—esophageal cancer	0.00107	0.00107	CcSEcCtD
Ertapenem—Pain—Capecitabine—esophageal cancer	0.00107	0.00107	CcSEcCtD
Ertapenem—Constipation—Capecitabine—esophageal cancer	0.00107	0.00107	CcSEcCtD
Ertapenem—Dermatitis—Cisplatin—esophageal cancer	0.00106	0.00106	CcSEcCtD
Ertapenem—Ill-defined disorder—Methotrexate—esophageal cancer	0.00105	0.00105	CcSEcCtD
Ertapenem—Anaemia—Methotrexate—esophageal cancer	0.00105	0.00105	CcSEcCtD
Ertapenem—Feeling abnormal—Capecitabine—esophageal cancer	0.00103	0.00103	CcSEcCtD
Ertapenem—Malaise—Methotrexate—esophageal cancer	0.00102	0.00102	CcSEcCtD
Ertapenem—Vertigo—Methotrexate—esophageal cancer	0.00102	0.00102	CcSEcCtD
Ertapenem—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00102	0.00102	CcSEcCtD
Ertapenem—Nausea—Cisplatin—esophageal cancer	0.001	0.001	CcSEcCtD
Ertapenem—Cough—Methotrexate—esophageal cancer	0.000991	0.000991	CcSEcCtD
Ertapenem—Urticaria—Capecitabine—esophageal cancer	0.000989	0.000989	CcSEcCtD
Ertapenem—Abdominal pain—Capecitabine—esophageal cancer	0.000985	0.000985	CcSEcCtD
Ertapenem—Body temperature increased—Capecitabine—esophageal cancer	0.000985	0.000985	CcSEcCtD
Ertapenem—Convulsion—Methotrexate—esophageal cancer	0.000984	0.000984	CcSEcCtD
Ertapenem—Chest pain—Methotrexate—esophageal cancer	0.000967	0.000967	CcSEcCtD
Ertapenem—Arthralgia—Methotrexate—esophageal cancer	0.000967	0.000967	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000961	0.000961	CcSEcCtD
Ertapenem—Discomfort—Methotrexate—esophageal cancer	0.000956	0.000956	CcSEcCtD
Ertapenem—Confusional state—Methotrexate—esophageal cancer	0.000935	0.000935	CcSEcCtD
Ertapenem—Anaphylactic shock—Methotrexate—esophageal cancer	0.000927	0.000927	CcSEcCtD
Ertapenem—Infection—Methotrexate—esophageal cancer	0.000921	0.000921	CcSEcCtD
Ertapenem—Hypersensitivity—Capecitabine—esophageal cancer	0.000918	0.000918	CcSEcCtD
Ertapenem—Nervous system disorder—Methotrexate—esophageal cancer	0.000909	0.000909	CcSEcCtD
Ertapenem—Thrombocytopenia—Methotrexate—esophageal cancer	0.000908	0.000908	CcSEcCtD
Ertapenem—Skin disorder—Methotrexate—esophageal cancer	0.000901	0.000901	CcSEcCtD
Ertapenem—Hyperhidrosis—Methotrexate—esophageal cancer	0.000896	0.000896	CcSEcCtD
Ertapenem—Asthenia—Capecitabine—esophageal cancer	0.000894	0.000894	CcSEcCtD
Ertapenem—Anorexia—Methotrexate—esophageal cancer	0.000884	0.000884	CcSEcCtD
Ertapenem—Pruritus—Capecitabine—esophageal cancer	0.000881	0.000881	CcSEcCtD
Ertapenem—Hypotension—Methotrexate—esophageal cancer	0.000866	0.000866	CcSEcCtD
Ertapenem—Diarrhoea—Capecitabine—esophageal cancer	0.000852	0.000852	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000845	0.000845	CcSEcCtD
Ertapenem—Insomnia—Methotrexate—esophageal cancer	0.000839	0.000839	CcSEcCtD
Ertapenem—Paraesthesia—Methotrexate—esophageal cancer	0.000833	0.000833	CcSEcCtD
Ertapenem—Dyspnoea—Methotrexate—esophageal cancer	0.000827	0.000827	CcSEcCtD
Ertapenem—Somnolence—Methotrexate—esophageal cancer	0.000824	0.000824	CcSEcCtD
Ertapenem—Dizziness—Capecitabine—esophageal cancer	0.000824	0.000824	CcSEcCtD
Ertapenem—Dyspepsia—Methotrexate—esophageal cancer	0.000816	0.000816	CcSEcCtD
Ertapenem—Decreased appetite—Methotrexate—esophageal cancer	0.000806	0.000806	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.0008	0.0008	CcSEcCtD
Ertapenem—Fatigue—Methotrexate—esophageal cancer	0.000799	0.000799	CcSEcCtD
Ertapenem—Pain—Methotrexate—esophageal cancer	0.000793	0.000793	CcSEcCtD
Ertapenem—Vomiting—Capecitabine—esophageal cancer	0.000792	0.000792	CcSEcCtD
Ertapenem—Rash—Capecitabine—esophageal cancer	0.000785	0.000785	CcSEcCtD
Ertapenem—Dermatitis—Capecitabine—esophageal cancer	0.000785	0.000785	CcSEcCtD
Ertapenem—Headache—Capecitabine—esophageal cancer	0.00078	0.00078	CcSEcCtD
Ertapenem—Feeling abnormal—Methotrexate—esophageal cancer	0.000764	0.000764	CcSEcCtD
Ertapenem—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000758	0.000758	CcSEcCtD
Ertapenem—Nausea—Capecitabine—esophageal cancer	0.00074	0.00074	CcSEcCtD
Ertapenem—Urticaria—Methotrexate—esophageal cancer	0.000737	0.000737	CcSEcCtD
Ertapenem—Abdominal pain—Methotrexate—esophageal cancer	0.000733	0.000733	CcSEcCtD
Ertapenem—Body temperature increased—Methotrexate—esophageal cancer	0.000733	0.000733	CcSEcCtD
Ertapenem—Hypersensitivity—Methotrexate—esophageal cancer	0.000683	0.000683	CcSEcCtD
Ertapenem—Asthenia—Methotrexate—esophageal cancer	0.000665	0.000665	CcSEcCtD
Ertapenem—Pruritus—Methotrexate—esophageal cancer	0.000656	0.000656	CcSEcCtD
Ertapenem—Diarrhoea—Methotrexate—esophageal cancer	0.000634	0.000634	CcSEcCtD
Ertapenem—Dizziness—Methotrexate—esophageal cancer	0.000613	0.000613	CcSEcCtD
Ertapenem—Vomiting—Methotrexate—esophageal cancer	0.00059	0.00059	CcSEcCtD
Ertapenem—Rash—Methotrexate—esophageal cancer	0.000585	0.000585	CcSEcCtD
Ertapenem—Dermatitis—Methotrexate—esophageal cancer	0.000584	0.000584	CcSEcCtD
Ertapenem—Headache—Methotrexate—esophageal cancer	0.000581	0.000581	CcSEcCtD
Ertapenem—Nausea—Methotrexate—esophageal cancer	0.000551	0.000551	CcSEcCtD
